JOHNSON & JOHNSON 4

EVP Vanessa Broadhurst exercised options and sold 23,054 Johnson & Johnson (JNJ) shares on 2026-07-20 for roughly $5.8 million, ending with 23,003 shares owned directly.

On July 20, 2026, Vanessa Broadhurst, EVP, Global Corporate Affairs of Johnson & Johnson, exercised two tranches of employee stock options to acquire a total of 23,054 shares of Johnson & Johnson common stock at exercise prices of $129.51 (11,129 shares) and $131.94 (11,925 shares), then sold all 23,054 shares in the open market at a weighted average price of $251.266 per share. The option exercises were from awards originally granted on February 12, 2021 and February 11, 2022, respectively, under the issuer’s long‑term incentive plan. Following these transactions, she reported direct ownership of 23,003 shares of common stock. Based on the sale price as a proxy for value, the gross sale proceeds were approximately $5.8 million and her post‑transaction direct holdings are worth roughly $5.8 million at prevailing prices, indicating a substantial but likely compensation‑related liquidity event rather than an open‑market purchase.

Filing Facts

CIK

200406

Ticker

JNJ

Form

4

Source Type

fda

Accession

0000200406-26-000148

Alert Tier

7